| 영문 | fibrin | 한글 | 섬유소 |
|---|---|---|---|
| 설명 | 피가 굳을 때 섬유소에 트롬빈이 작용하여 생기는 섬유 같은 단백질. 무색이나 엷은 황색을 띤 고체로, 물에 잘 녹지 않으며 혈구와 엉키어 피를 굳게 하여 출혈을 그치게 한다. |
||
| SFC | soluble fibrin complex; soluble fibrin-fibrinogen complex; spinal fluid count |
|---|---|
| GF | gastric fistula; gastric fluid; germ-free; glass factor; glomerular filtration; gluten-free; grandfa... |
| GFD | gingival fibromatosis-progressive deafness [syndrome]; gluten-free diet |
| GSE | general somatic efferent; gluten-sensitive enteropathy |
| FSF | Fibrin Stabilizing Factor(Factor XIII) |
| GFD | Gluten Free Diet |
|---|---|
| GSE | Gluten sensitive enteropathy |
| -CGM | corn gluten meal |
| FDP | Fibrin Degradation Product |
| FbDP | Fibrin Degradation Products |
| gluten | <protein> The protein of wheat and other grains which gives to the dough its tough elastic character. (18 Nov 1997) |
|---|---|
| gluten enteropathy | <gastroenterology> An inherited disease where the intestinal lining is inflamed in response to the ingestion of a protein known as gluten. Gluten is present in many grains including rye, oats, barley and triticale. Symptoms in infants include diarrhoea, slow growth, bloody stools, weight loss, vomiting and clay-coloured stools. Symptoms in adults include abdominal distention, abdominal pain, fatigue, weight loss, bone pain and bone tenderness. Treatment involves the life-long avoidance of gluten. Origin: Gr. Pathos = disease (27 Sep 1997) |
| gluten-free diet | Elimination of all wheat, rye, barley, and oat gluten from the diet; treatment for gluten-sensitive enteropathy (coeliac disease). See: coeliac disease. (05 Mar 2000) |
| enteropathy, gluten | A condition in which the absorption of food nutrients through the small intestine is impaired because of an immune (allergic) reaction to gluten, a protein found in wheat or related grains and many other foods. Frequent diarrhoea and weight loss can be symptoms. A skin condition called dermatitis herpetiformis can be associated with gluten enteropathy. The most accurate test is a biopsy of the involved small bowel. Treatment is avoidance of gluten in the diet. Medications are used, if need be. (12 Dec 1998) |
| human fibrin foam | A dry artificial sponge of human fibrin prepared by clotting with thrombin a foam of a solution of human fibrinogen; the clotted foam is dried from the frozen state and heated; used as a topical anticoagulant. (05 Mar 2000) |
| fibrin | <protein> The insoluble protein formed from fibrinogen by the proteolytic action of thrombin during normal clotting of blood. Fibrin forms the essential portion of the blood clot. (12 Nov 1997) |
| fibrin calculus | A urinary calculus formed largely from fibrinogen in blood. (05 Mar 2000) |
| fibrin degradation products | <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot. Normal value is less than 10 mcg/ml (micrograms per millilitre). They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia. Acronym: FDP (23 Sep 2002) |
| fibrin destabilase | <enzyme> Hydrolyses the epsilon-(gamma-glutamyl)-lysine bonds of stabilised fibrin Pharmacological action: fibrinolytic agents Registry number: EC 3.4.99.- Synonym: destabilase (26 Jun 1999) |
| fibrin fibrinogen degradation products | <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis. Pharmacological action: antithrombins. (12 Dec 1998) |
| fibrin foam | <chemical> A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a haemostatic in surgery at sites where bleeding cannot be controlled by more common methods. Pharmacological action: haemostatics, tissue adhesives. (12 Dec 1998) |
| fibrinogen-fibrin conversion syndrome | <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma. (05 Mar 2000) |
| fibrin-stabilizing factor | <chemical> Fibrin stabilizing factor. It is a glycoprotein activated by thrombin in the presence of calcium to form factor xiiia. Factor xiii is found evenly distributed between plasma and platelets. Its function is to stabilise the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Chemical name: Blood-coagulation factor XIII (12 Dec 1998) |
| fibrin thrombus | A thrombus formed by repeated deposits of fibrin from the circulating blood; it usually does not completely occlude the vessel. (05 Mar 2000) |
| fibrin tissue adhesive | <chemical> An autologous or commercial tissue adhesive containing fibrinogen and thrombin. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, factor viii, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agent such as aprotinin. Mixing of the two components promotes clotting and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, haemostasis, and wound healing. Pharmacological action: haemostatics, tissue adhesives. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|